Professional summary
Greg Yap is a Partner at Menlo Ventures investing in teams solving major problems in life science and healthcare. His stated areas of interest include novel therapeutic platforms, digital health, and transformative technologies, with Menlo also tagging his profile for Bio + Healthcare and AI. Before Menlo, he was an entrepreneur-in-residence at Illumina Ventures focused on genomics investments and spent two decades in senior executive and entrepreneurial roles in life science and digital health. He co-founded and led BlueLight Therapeutics and PyrAmes, and previously held leadership roles at Roche Diagnostics/Ventana, GE, Cellpoint Diagnostics, Affymetrix, and McKinsey.
Stage, sector, and overall fit
Selected portfolio companies the partner has backed
Framing and angles for outreach
Lead with a rigorous healthcare or life-science thesis, the scientific or clinical wedge, and why the team can translate technology into a scalable company. He appears especially relevant for AI-enabled therapeutics, genomics, digital health, and platforms that connect deep biology with large healthcare problems.
What the partner has said or done recently
Menlo profile lists Chai Discovery as a 2025 Series A partnership focused on AI models for biochemical interactions.
Menlo profile lists Aurora Therapeutics as a 2025 company incubated by Menlo Ventures, with Greg Yap shown as a partner.
Menlo profile highlights his Aspen Health Innovators Fellowship and Aspen Global Leadership Network membership.
12 more profiles
Partner
Menlo Ventures
Amy Wu Martin is a Partner at Menlo Ventures focused on AI and consumer companies, with a background in consumer technology, gaming, blockchain, and digital media. She joined Menlo to grow its consumer technology and gaming practice.
Principal
Menlo Ventures
Menlo principal investing in consumer tech, SaaS, and AI applications.
Partner
Menlo Ventures
Croom Beatty is a Partner at Menlo Ventures focused on application-layer AI, fintech, healthcare IT, and vertical software. Since joining Menlo in 2017, he has led investments in companies including Arch, Finch, Manifest, NationGraph, Numeric, Prodigal, Rivet, Slash, Abacus, Accordance, Relcu, and Squad Health.
General Counsel, Partner
Menlo Ventures
General Counsel and Partner overseeing legal, fund, deal, and compliance work at Menlo.
Partner
Menlo Ventures
Early-stage AI, infrastructure, and enterprise software investor; ex-Glean, Google, and Facebook.
Principal
Menlo Ventures
Menlo principal backing AI, cloud infrastructure, and digital health startups.
Partner Emeritus
Menlo Ventures
Longtime Menlo IT investor behind Hotmail, IronPort, Ansible, nLight, and Synthego.
Partner, Business & Corporate Development
Menlo Ventures
Business development partner helping Menlo portfolio companies scale through partnerships.
Investor
Menlo Ventures
Menlo investor focused on AI/ML, SaaS, and cloud infrastructure.
Partner
Menlo Ventures
Inflection-stage investor focused on vertical SaaS, enterprise software, and future of work.
Partner
Menlo Ventures
Joff Redfern is a partner at Menlo Ventures focused on software development workflows, AI-driven future-of-work products, and network-effect businesses including marketplaces.
Principal
Menlo Ventures
Menlo principal investing in biotech, life sciences, and novel therapeutics.